Bielasz Jennifer Kathleen 4
4 · ARENA PHARMACEUTICALS INC · Filed Mar 30, 2012
Insider Transaction Report
Form 4
Bielasz Jennifer Kathleen
Sr. Dir. of Accounting & Cont.
Transactions
- Sale
Common Stock
2012-03-29$3.04/sh−6,250$19,001→ 9,350 total - Exercise/Conversion
Common Stock
2012-03-29$1.49/sh+6,250$9,313→ 15,600 total - Sale
Common Stock
2012-03-29$3.01/sh−4,550$13,696→ 4,800 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-29−6,250→ 18,750 totalExercise: $1.49Exp: 2021-03-15→ Common Stock (6,250 underlying)
Holdings
- 30(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The reporting person paid the issuer a total of $34.20 for the difference between the $1.90 per share price of the 30 shares her son purchased on February 1, 2012, and the $3.0401 per share price of 30 of the shares sold by the reporting person and reported on this line.
- [F2]The options, representing the right to purchase a total of 25,000 shares, vest in four equal annual installments beginning on March 15, 2012, which was the first anniversary of the date on which the options were granted. The options are exercisable once vested.